Cyclerion Therapeutics (CYCN) Free Cash Flow (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Free Cash Flow of -$264000.0 in Q3 2025, up 47.51% quarter-over-quarter from -$503000.0 in Q2 2025, and up 84.62% on a YoY basis from -$143000.0 in Q3 2024.
Cyclerion Therapeutics (CYCN) Free Cash Flow (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$264000.0 for Q3 2025.
- In Q3 2025, Free Cash Flow rose 84.62% year-over-year to -$264000.0; the TTM figure through Dec 2025 stood at -$1.7 million (up 59.96% YoY), while the FY2024 annual figure was -$4.3 million, up 79.6% from the prior year.
- Free Cash Flow was -$264000.0 for Q3 2025 at Cyclerion Therapeutics, up from -$503000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $360000.0 in Q4 2024 to a low of -$14.5 million in Q1 2021.
- Historically, Free Cash Flow has averaged -$5.5 million across 5 years, with a median of -$6.2 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow tumbled 96.37% in 2022, then surged 123.36% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$8.6 million in 2021, then gained by 18.39% to -$7.0 million in 2022, then soared by 78.12% to -$1.5 million in 2023, then soared by 123.36% to $360000.0 in 2024, then slumped by 173.33% to -$264000.0 in 2025.
- The last three Free Cash Flow figures came in at -$264000.0 (Q3 2025), -$503000.0 (Q2 2025), and -$968000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 63,220.27 |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -264,000.00 |
| Sep 30, 2025 | -264,000.00 |
| Jun 30, 2025 | -503,000.00 |
| Jun 30, 2025 | -503,000.00 |
| Mar 31, 2025 | -968,000.00 |
| Mar 31, 2025 | -968,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Sep 30, 2024 | -1.72 Mn |
| Sep 30, 2024 | -1.72 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Sep 30, 2023 | -6.94 Mn |
| Sep 30, 2023 | -6.94 Mn |
| Jun 30, 2023 | -6.56 Mn |
| Jun 30, 2023 | -6.56 Mn |